Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
20.86
+0.96 (4.80%)
At close: Aug 13, 2025, 4:00 PM
20.85
0.00 (-0.02%)
After-hours: Aug 13, 2025, 4:10 PM EDT
Dianthus Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$53.00
Upside
+154.14%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 2, 2025 |
| Baird | Baird | Buy Maintains $58 → $50 | Buy | Maintains | $58 → $50 | +139.75% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +91.80% | May 13, 2025 |
| Wedbush | Wedbush | Buy Reiterates $36 | Buy | Reiterates | $36 | +72.62% | Mar 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $84 | Strong Buy | Reiterates | $84 | +302.78% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +91.80% | Mar 12, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +91.80% | Nov 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $48 → $52 | Buy | Maintains | $48 → $52 | +149.34% | Nov 11, 2024 |
| Raymond James | Raymond James | Buy Maintains $51 → $56 | Buy | Maintains | $51 → $56 | +168.52% | Nov 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $48 | Buy | Initiates | $48 | +130.16% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +91.80% | Sep 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +91.80% | Aug 12, 2024 |
| Wedbush | Wedbush | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +72.62% | Aug 9, 2024 |
| Baird | Baird | Buy Initiates $58 | Buy | Initiates | $58 | +178.11% | Jul 26, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.